From the point of view of amelioration of the disease, it is remarkable that transfer of TCRαβ+CD8α+ IELs restrained spontaneous colitis, consistent with previous reports that the cells have an ability to suppress gut inflammation [19,20,22,34]. The gene discussed is CD8A; the disease is colitis.